David Genecov

David Genecov has an extensive work experience history. David is currently the President and CEO, as well as a Co-Founder, of Dialectic Therapeutics Inc since April 2019. Prior to this, they were the Chief Medical Officer, Co-Founder, and Director of Cessation Therapeutics, LLC starting from June 2018. In 2007, they became the Managing Partner of Pediatric Plastic Surgery PLLC, and in 2006, they served as the Director of International Craniofacial Institute. David also held the position of President at Genecov Plastic Surgery Group starting from July 1997. Additionally, they were a Director at CerSci Therapeutics Inc from May 2017 to August 2020. From April 2013 to April 2016, they were a Co-Founder and Director at AveXis, Inc., which was later acquired by Novartis. Lastly, they were a Co-Founder and Director at BioLife Cell Bank from March 2010 to April 2014.

David Genecov completed their education history as follows:

- From 1982 to 1985, they attended The University of Texas at Austin where they earned a Bachelor of Arts degree in Plan II Honors.

- David then attended UT Health San Antonio from 1986 to 1990, where they obtained a Doctor of Medicine (MD) degree in Medicine.

- Continuing their education, David Genecov enrolled in West Virginia University from 1990 to 1995 for their General Surgery Residency, focusing on General Surgery.

- Following that, they pursued further specialization at Wake Forest University Graduate School, where they completed a Plastic Surgery Fellowship in Plastic and Reconstructive Surgery from 1995 to 1997.

- Lastly, from 1997 to 1998, they attended the International Craniofacial Institute/Cleft Lip and Palate Treatment Center for a Craniofacial Surgery Fellowship, specializing in Craniomaxillofacial Surgery.